RNAC

6.1404.24%
MS

Michael Scott Singer

Independent Director

Dr. Michael Scott Singer, M.D, PhD, also known as Mike, serves as Member of Advisory Board of Cellens Inc. He is Director & Senior Advisor of Anodyne Nanotech, Inc. He serves as an Independent Director of Cartesian Therapeutics, Inc. since November 13, 2023. Dr. Singer served as Director at Selecta Biosciences, Inc. since November 13, 2023. Dr. Singer serves as Member of Strategic Advisory Board at iVexSol Inc. He served as a Chief Strategy Officer & Chairman at Cartesian Therapeutics, Inc. since February 2023. He was a Chief Scientific Officer at Cartesian Therapeutics, Inc. since 2016 until February 2023. Dr. Singer co-founded and was Chairman of the Board of Cartesian Therapeutics, Inc. from 2016 until its acquisition by the Company in 2023. He is a Senior Advisor and has been Director of Anodyne Nanotech, Inc. since 2020. He co-founded Healthhonors Corporation in 2006. Dr. Singer has been Member of Advisory Board at QSM Diagnostics, Inc. since 2020. He co-founded and served as the Chief Scientific Officer at Topokine Therapeutics, Inc. from 2012 to 2016 and Healthhonors Corporation from 2006 to 2009. also served as its Chief Scientific and Medical Officer. He served as a medical Director at Novartis from 2009 to 2012 and Boston Scientific and Chief scientist at HealthHonors, he has supervised development of numerous new therapies. His research spans over many years in the basic and clinical sciences, with award of competitive grants and publications in journals such as Nature and PNAS. Dr. Singer is a licensed, board-certified physician. He had been Independent Director of BioPorto A/S since August 15, 2019 until April 12, 2025. He serves as Independent Director of Pykus Therapeutics, Inc. since 2019. He also served as Director of Translational Medicine at Novartis and a physician at Harvard and the U.S. Veterans Affairs Medical Center. He volunteers on the Board of Museum Advisors at the Museum of Science, Boston. He serves as Member of the advisory Board of IvexSol, Incorporated. He has served as a Surgeon in the Veterans Health Administration and serves on the clinical faculty at Harvard Medical School. Dr. Singer completed residency at Harvard and holds a BS in Biology, MD, M.Phil & PhD in Neuroscience from Yale University.

公司职务